Riskpilot← Back to searchSign inGet full accessEmercitius AB
ABActiveOrg 5591383087Fortvägen 19Medical specialists activities · NACE 8622Est. 20171 employees
Revenue 2024
SEK 743K
+9% vs 2023
EBITDA margin
63.5%
+12% vs 2023
Equity ratio
85.5%
Financial strength
Net profit 2024
SEK 368K
+10% vs 2023
| Revenue | SEK 743K | +9% |
| EBITDA | SEK 472K | +12% |
| Net profit | SEK 368K | +10% |
| Total assets | SEK 628K | +29% |
| Equity | SEK 537K | +23% |
| Employees | 1 | — |
Legal name
Emercitius AB
Org number
5591383087
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 december 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska utföra tjänster inom medicinsk konsultation och därmed förenlig verksamhet. Bolaget har också till föremål att direkt eller indirekt äga, förvalta och handla med fast och lös egendom såsom fastigheter och värdepapper samt därmed förenlig verksamhet.
Address
Fortvägen 19
Email
nikolaj.platkov@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 371 | 777 | 389 | 304 | 444 | 683 | 743 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 250 | 6 | 149 | 200 | 243 | 423 | 472 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −10 |
| EBIT | 250 | 6 | 149 | 200 | 243 | 423 | 462 |
| Net financials | — | — | — | — | — | 1 | 1 |
| Profit before tax | 250 | 6 | 149 | 200 | 242 | 424 | 463 |
| Tax | −55 | −1 | −32 | −41 | −50 | −88 | −95 |
| Net profit | 195 | 5 | 117 | 159 | 192 | 336 | 368 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 307 | 199 | 266 | 243 | 330 | 488 | 628 |
| Equity | 245 | 80 | 198 | 357 | 549 | 438 | 537 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 62 | 119 | 68 | 113 | 218 | 51 | 91 |
| Total debt | 62 | 119 | 68 | 113 | 218 | 51 | 91 |
EBITDA margin
63.5%
This company
15.8%
Market median
+302% vs market
20182024
Equity ratio
85.5%
This company
38.2%
Market median
+124% vs market
20182024
Return on equity
68.5%
This company
18.4%
Market median
+272% vs market
20182024
Net profit margin
49.5%
This company
8.1%
Market median
+511% vs market
20182024
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
20182024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20182024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-12-01 – 2018-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2024 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Emercitius AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniils Platkovs | Deputy Board Member | 0 companies |
| Anette Susanne Quistgaard | Deputy Board Member | 0 companies |
| Nikolajs Platkovs | Board of Directors | 0 companies |